EP
CBAY

Eversept Partners’s Cymabay Therapeutics CBAY Stock Holding History

Eversept Partners’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-84,296
Closed -$604K – 67
2019
Q2 		$604K Sell
84,296
-23,000
-21% -$260K 0.17% 54
2019
Q1 		$1.42M Buy
107,296
+60,200
+128% +$640K 0.42% 36
2018
Q4 		$371K Sell
47,096
-25,000
-35% -$238K 0.21% 47
2018
Q3 		$799K Sell
72,096
-35,000
-33% -$435K 0.4% 40
2018
Q2 		$1.44M Buy
+107,096
New +$1.34M 0.7% 31

Other funds holding CBAY

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return